StockData
Schrodinger, Inc. logo

Schrodinger, Inc. (SDGR) stock

SDGRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3053% above fair value
$25.66−1.70 (-6.21%)

Close on Nov 17, 2026Market cap $1.92BP/E –Yield –

Schrodinger operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Schrodinger's operating cash flow for the twelve months ending Jun 30, 2026 was -$126.87M, down 561.4% year over year. For fiscal 2025 it was $13.90M. The highest annual figure on record is $16.76M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$13.90M–
FY2024Dec 31, 2024-$157.37M–
FY2023Dec 31, 2023-$136.73M–
FY2022Dec 31, 2022-$119.68M–
FY2021Dec 31, 2021-$70.67M-521.7%
FY2020Dec 31, 2020$16.76M–
FY2019Dec 31, 2019-$26.06M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$34.07M–
Q1 FY2026Mar 31, 2026-$14.83M-110.3%
Q4 FY2025Dec 31, 2025-$16.09M–
Q3 FY2025Sep 30, 2025-$61.87M–
Q2 FY2025Jun 30, 2025-$52.20M–
Q1 FY2025Mar 31, 2025$144.06M–
Q4 FY2024Dec 31, 2024-$31.11M–
Q3 FY2024Sep 30, 2024-$33.26M–
Q2 FY2024Jun 30, 2024-$53.72M–
Q1 FY2024Mar 31, 2024-$39.28M–
Q4 FY2023Dec 31, 2023-$37.26M–
Q3 FY2023Sep 30, 2023-$49.94M–
Q2 FY2023Jun 30, 2023-$18.44M–
Q1 FY2023Mar 31, 2023-$31.09M–
Q4 FY2022Dec 31, 2022-$24.94M–
Q3 FY2022Sep 30, 2022-$30.36M–
Q2 FY2022Jun 30, 2022-$24.67M–
Q1 FY2022Mar 31, 2022-$39.71M–
Q4 FY2021Dec 31, 2021-$19.74M-145.3%
Q3 FY2021Sep 30, 2021-$10.64M–
Q2 FY2021Jun 30, 2021-$29.37M–
Q1 FY2021Mar 31, 2021-$10.92M–
Q4 FY2020Dec 31, 2020$43.62M–
Q3 FY2020Sep 30, 2020-$12.03M–
Q2 FY2020Jun 30, 2020-$9.05M–
Q1 FY2020Mar 31, 2020-$5.78M–
Q4 FY2019Dec 31, 2019-$11.27M–
Q3 FY2019Sep 30, 2019-$5.93M–
Q2 FY2019Jun 30, 2019-$4.24M–
Q1 FY2019Mar 31, 2019-$4.62M–

More Schrodinger figures

See a number that looks wrong?